VAD Therapy Trends: Why Meaningful Data Matters

Originally Broadcast December 10, 2020

Hear key opinion leaders from around the world share their experience in mechanical circulatory support. Join us for a discussion exploring data and trends in surgical approach, right heart failure and patient management to achieve excellent outcomes for patients implanted with the HVAD System.

Featured Faculty


Stephan Schueler, MD, PhD, FRCS - Moderator

Consultant Cardiothoracic and Transplant Surgeon
Freeman Hospital
Newcastle upon Tyne, United Kingdom


Anson Cheung, MD

Director, Cardiac Transplantation of British Columbia
Clinical Associate Professor of Surgery
University of British Columbia, St. Paul's Hospital
British Columbia, Canada


Erika Feller, MD

Associate Professor of Medicine
Medical Director, Mechanical Circulatory Support and Transplant
Director of Cardiology Clinical Research
University of Maryland Medical Center
Maryland, United States


Prof. Dr. med. Evgenij V. Potapov
Senior Cardiac Surgeon
Head Ventricular Assist Device Team
Department of Cardiothoracic and Vascular Surgery
Deutsches Herzzentrum Berlin
Berlin, Germany


Christopher T. Salerno, MD, FACS, FACC

Surgical Director Heart Transplant and Mechanical Assist Device Program
St. Vincent Heart Center of Indiana
Chief, Cardiothoracic Surgery
Vice Chair Surgery, St Vincent Hospital
Indiana, United States


This is an independent event and is not an official part of ISHLTv

Click here to visit ISHLTv Virtual Education where you can listen to webinars and read the ePresentations as well as visit the Virtual Exhibit Hall.

U.S. Brief Statement: Medtronic HVAD System
Indications For Use: The Medtronic HVAD System is indicated for hemodynamic support in patients with advanced, refractory left ventricular heart failure; either as a Bridge to Cardiac Transplantation (BTT), myocardial recovery, or as Destination Therapy(DT) in patients for whom subsequent transplantation is not planned.
Contraindications: The HVAD System is contraindicated in patients who cannot tolerate anticoagulation therapy.
Warnings/Precautions: Proper usage and maintenance of the HVAD System is critical for the functioning of the device. Serious and life-threatening adverse events, including stroke, have been associated with use of this device. Blood pressure management may reduce the risk of stroke. Never disconnect from two power sources at the same time (batteries or power adapters) since this will stop the pump, which could lead to serious injury or death. At least one power source must be connected at all times. Always keep a spare controller and fully charged spare batteries available at all times in case of an emergency. Do not disconnect the driveline from the controller or the pump will stop. Avoid devices and conditions that may induce strong static discharges as this may cause the VAD to perform improperly or stop. Magnetic resonance imaging (MRI) could cause harm to the patient or could cause the pump to stop. The HVAD Pump may cause interference with automatic implantable cardioverter-defibrillators (AICDs), which may lead to inappropriate shocks, arrhythmia and death. Chest compressions may pose a risk due to pump location and position of the outflow graft on the aorta -use clinical judgment. If chest compressions have been administered, confirm function and positioning of HVAD Pump post CPR.
Potential Complications: Implantation of a VAD is an invasive procedure requiring general anesthesia and entry into the thoracic cavity. There are numerous known risks associated with this surgical procedure and the therapy including, but not limited to, death, stroke, neurological dysfunction, device malfunction, peripheral and device-related thromboembolic events, bleeding, right ventricular failure, infection, hemolysis and sepsis. Refer to the “Instructions for Use” for detailed information regarding the implant procedure, indications, contraindications, warnings, precautions and potential adverse events prior to using this device.
Caution: Federal law (USA) restricts these devices to sale by or on the order of a physician.

Disclaimer:This content is provided for general educational purposes only and should not be considered the exclusive source for this type of information. This training does not replace or supersede approved labeling. The content will be shared with physicians and allied health professionals who seek a deeper understanding of the operation and use of Medtronic products and therapies with the intent of enhancing their knowledge of features and operations described in the HVAD System labeling. Patient information (names, serial numbers, date, etc.) has been changed or removed to protect the privacy of the patients used in this content. At all times, it is the professional responsibility of the practitioner to exercise independent clinical judgment in a particular situation. Changes in a patient’s disease and/or medications may alter the efficacy of a device’s programmed parameters or related features and results may vary.

Important Reminder
This information is intended only for users in markets where Medtronic products and therapies are approved or available for use as indicated within the respective product manuals. Content on specific Medtronic products and therapies is not intended for users in markets that do not have authorization for use.

This faculty is being paid as a consultant for the services being provided in accordance with applicable laws and regulations.

MCS EU Brief Statement:
See the HVADTM System instructions for use for detailed information regarding the instructions for use, the implant procedure, indications, contraindications, warnings, precautions, and potential adverse events. For further information, contact your local Medtronic representative and/or consult the Medtronic website at

UC code: UC202112043 EE


October 20, 2020

Created by

Medtronic Virtual MCS